Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Liver Diseases × Lead × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 4 Brain Neoplasms 3 Neoplasms 2 Lung Neoplasms 2 Thrombophilia 1 Stomatitis 1 Stomach Neoplasms 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Periodontitis 1 Neoplasms, Plasma Cell 1 Motor Activity 1 Liver Neoplasms 1 Liver Diseases 1 Head and Neck Neoplasms 1 Glioblastoma 1 Gastrointestinal Stromal Tumors 1 Febrile Neutropenia 1 EGFR-Mutant Lung Cancer 1 Deglutition Disorders 1 Communication Disorders 1 Colorectal Neoplasms 1 Central Nervous System Neoplasms 1 Carcinoma, Pancreatic Ductal 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1 Blood Coagulation Disorders 1 Adenocarcinoma 1

Interventions

Sorafenib 5 Blood Specimen Collection 3 pembrolizumab 2 lenvatinib 2 ledipasvir, sofosbuvir drug combination 2 halofantrine 2 camrelizumab 2 atezolizumab 2 Liver Transplantation 2 Immunotherapy 2 Control Groups 2 Bevacizumab 2 trifluridine tipiracil drug combination 1 trametinib 1 toripalimab 1 titanium silicide 1 tislelizumab 1 sintilimab 1 rubitecan 1 repotrectinib 1 pevonedistat 1 ozanimod 1 linifanib 1 genexol-PM 1 gadolinium ethoxybenzyl DTPA 1 fluorocholine 1 fisogatinib 1 ficlatuzumab 1 durvalumab 1 belinostat 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05931068 2024-08-05

PRO-NRG

Academisch Ziekenhuis Maastricht

Gastrointestinal

Liver Diseases, Liver Neoplasms, Motor Activity, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡